Drug recall · December 2, 2020
clomiPRAMINE Hydrochloride Capsules USP recall
Why: Failed Tablet/Capsule Specification
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
- Lots / codes
Lot# 20P0141, exp. date 02/2022
- Quantity
- 4,416 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Product was distributed nationwide.
- Initiated
- November 6, 2020 · Voluntary: Firm initiated
- Classified
- November 24, 2020
- Reported
- December 2, 2020
- Ended
- March 23, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clomipramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.